Actor
Calliditas Therapeutics Suisse SA (former GenKyoTex SA)
Leading biopharmaceutical company developing NOX therapies. Its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.10 Small Molecules
Business model
1. Entreprise
1.5 Multinational
Organization Type
Private Company
Visit website
Domains
Cardiovascular & Hematology, Endocrine & Metabolic, Neurology, Oncology
Main sector
Biotech
Contact
Chemin des Aulx 16
1228 Plan-les-Ouates / GE
022 880 10 25